| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 7 | -189,701 | 100% | $18.00 | -$3,413,698 |
| Net | -7 | -189,701 | -100% | -$3,413,698 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| John Walter Hanna Jr. | President and CEO, Director | $16,006,074 | -$626,027 | -3.8% | 02 Feb 2026 |
| Alexander L. Johnson | President of Patient and Testing Services | $9,284,746 | 20 Aug 2024 | ||
| Abraham Ronai | Officer | $6,160,873 | 20 Sep 2023 | ||
| Peter Maag | Director | $5,745,904 | -$607,047 | -9.6% | 07 Jul 2025 |
| Reginald Seeto | President and Chief Executive Officer, Director | $5,721,218 | 02 Oct 2023 | ||
| Keith Kennedy | Chief Operating Officer | $4,270,618 | 02 Feb 2026 | ||
| Abhishek Jain | Chief Financial Officer | $3,907,039 | -$4,696 | -0.12% | 01 Aug 2025 |
| Jessica Meng | Chief Commercial Officer | $3,609,806 | 02 Feb 2026 | ||
| Michael Goldberg | Director | $2,966,565 | 06 Jan 2026 | ||
| Fred E. Cohen | Director | $2,811,026 | 13 Jun 2025 | ||
| Jeffrey Adam Novack | Secretary and General Counsel | $2,576,894 | -$363,081 | -12% | 02 Feb 2026 |
| Sasha King | Chief Marketing Officer | $1,697,173 | 09 Aug 2022 | ||
| Nathan Smith | Chief Financial Officer | $1,613,506 | 02 Feb 2026 | ||
| William A. Hagstrom | Director | $1,158,857 | -$909,331 | -44% | 11 Jun 2025 |
| George Bickerstaff | Director | $1,148,357 | 11 Sep 2025 | ||
| Arthur A. Torres | Director | $949,139 | 13 Jun 2025 | ||
| Christine Cournoyer | Director | $947,611 | -$700,951 | -43% | 13 Jun 2025 |
| Hannah Valantine | Director | $747,288 | -$202,566 | -21% | 18 Jun 2025 |
| Ralph Snyderman | Director | $694,633 | 04 Oct 2022 | ||
| Richard Bryan Riggsbee | Director | $602,891 | 13 Jun 2025 | ||
| Ankur Dhingra | Chief Financial Officer | $455,463 | 25 Mar 2022 | ||
| Suresh Gunasekaran | Director | $399,166 | 22 Oct 2025 | ||
| Grace Colon | Director | $283,074 | 16 Jun 2023 |
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -3.42% | $91,286 | $20.56 | -4,441 | 125,364 | 03 Feb 2026 | Direct |
| Nathan Smith | CDNA | Common Stock | Tax liability | -4.66% | -3,859 | 79,016 | 02 Feb 2026 | Direct | ||
| Nathan Smith | CDNA | Common Stock | Award | 97.3% | 40,875 | 82,875 | 02 Feb 2026 | Direct | ||
| Jessica Meng | CDNA | Common Stock | Tax liability | -2.44% | -4,430 | 176,778 | 02 Feb 2026 | Direct | ||
| Jessica Meng | CDNA | Common Stock | Award | 65.3% | 71,579 | 181,208 | 02 Feb 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -4.04% | -5,462 | 129,805 | 02 Feb 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Award | 38.1% | 37,342 | 135,267 | 02 Feb 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Tax liability | -1.72% | -13,694 | 783,843 | 02 Feb 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Award | 33.5% | 200,132 | 797,537 | 02 Feb 2026 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Tax liability | -2.17% | -4,644 | 209,139 | 02 Feb 2026 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Award | 53.5% | 74,474 | 213,783 | 02 Feb 2026 | Direct | ||
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -3.13% | $408,023 | $21.16 | -19,280 | 597,405 | 22 Jan 2026 | Direct |
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -0.03% | $4,200 | $21.00 | -200 | 616,685 | 21 Jan 2026 | Direct |
| John Walter Hanna Jr. | CDNA | Common Stock | Sale | -1.62% | $213,804 | $21.05 | -10,156 | 616,885 | 15 Jan 2026 | Direct |
| Michael Goldberg | CDNA | Common Stock | Award | 0.96% | 1,492 | 157,461 | 06 Jan 2026 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -6.93% | $139,804 | $19.17 | -7,293 | 97,925 | 04 Dec 2025 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -2.49% | $41,723 | $15.52 | -2,688 | 105,218 | 07 Nov 2025 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -1.96% | -2,152 | 107,906 | 06 Nov 2025 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -2.54% | -2,872 | 110,058 | 01 Nov 2025 | Direct | ||
| Suresh Gunasekaran | CDNA | Common Stock | Award | 27,453 | 27,453 | 22 Oct 2025 | Direct | |||
| Michael Goldberg | CDNA | Common Stock | Award | 1.14% | 1,753 | 155,969 | 06 Oct 2025 | Direct | ||
| Jessica Meng | CDNA | Common Stock | Tax liability | -4.11% | -4,703 | 109,629 | 12 Sep 2025 | Direct | ||
| Keith Kennedy | CDNA | Common Stock | Tax liability | -5.42% | -7,987 | 139,309 | 12 Sep 2025 | Direct | ||
| George Bickerstaff | CDNA | Common Stock | Options Exercise | 25.3% | 29,136 | 144,266 | 11 Sep 2025 | Direct | ||
| George Bickerstaff | CDNA | Stock Option (right to buy) | Options Exercise | -100% | -29,136 | 0 | 11 Sep 2025 | Direct | ||
| Nathan Smith | CDNA | Common Stock | Award | 42,000 | 42,000 | 07 Aug 2025 | Direct | |||
| Jeffrey Adam Novack | CDNA | Common Stock | Sale | -2.32% | $34,381 | $12.79 | -2,688 | 112,930 | 05 Aug 2025 | Direct |
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -2.42% | -2,873 | 115,618 | 01 Aug 2025 | Direct | ||
| Abhishek Jain | CDNA | Common Stock | Tax liability | -2.35% | -7,687 | 319,725 | 01 Aug 2025 | Direct | ||
| Michael Goldberg | CDNA | Common Stock | Award | 0.8% | 1,218 | 154,216 | 08 Jul 2025 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -0.23% | -276 | 118,491 | 07 Jul 2025 | Direct | ||
| Peter Maag | CDNA | Common Stock | Sale | -3.14% | $185,831 | $18.58 | -10,000 | 308,846 | 07 Jul 2025 | Direct |
| Hannah Valantine | CDNA | Common Stock | Sale | -21.3% | $202,566 | $19.16 | -10,570 | 38,994 | 18 Jun 2025 | Direct |
| Peter Maag | CDNA | Common Stock | Sale | -3.04% | $192,420 | $19.24 | -10,000 | 318,846 | 17 Jun 2025 | Direct |
| Michael Goldberg | CDNA | Common Stock | Award | 8.59% | 12,103 | 152,998 | 13 Jun 2025 | Direct | ||
| Fred E. Cohen | CDNA | Common Stock | Award | 8.45% | 12,103 | 155,265 | 13 Jun 2025 | Direct | ||
| Peter Maag | CDNA | Common Stock | Award | 3.82% | 12,103 | 328,846 | 13 Jun 2025 | Direct | ||
| Richard Bryan Riggsbee | CDNA | Common Stock | Award | 69.5% | 12,103 | 29,517 | 13 Jun 2025 | Direct | ||
| George W. Bickerstaff III | CDNA | Common Stock | Award | 11.8% | 12,103 | 115,130 | 13 Jun 2025 | Direct | ||
| Hannah Valantine | CDNA | Common Stock | Award | 32.3% | 12,103 | 49,564 | 13 Jun 2025 | Direct | ||
| Christine Cournoyer | CDNA | Common Stock | Award | 32.7% | 12,103 | 49,148 | 13 Jun 2025 | Direct | ||
| Arthur A. Torres | CDNA | Common Stock | Award | 32.6% | 12,103 | 49,235 | 13 Jun 2025 | Direct | ||
| William A. Hagstrom | CDNA | Common Stock | Sale | -26.4% | $385,918 | $19.90 | -19,391 | 53,979 | 11 Jun 2025 | Direct |
| William A. Hagstrom | CDNA | Common Stock | Options Exercise | 35.9% | 19,391 | 73,370 | 11 Jun 2025 | Direct | ||
| William A. Hagstrom | CDNA | Stock Option (right to buy) | Options Exercise | -100% | -19,391 | 0 | 11 Jun 2025 | Direct | ||
| Jeffrey Adam Novack | CDNA | Common Stock | Tax liability | -2.13% | -2,583 | 118,767 | 06 Jun 2025 | Direct | ||
| William A. Hagstrom | CDNA | Common Stock | Sale | -35.7% | $523,413 | $17.45 | -30,000 | 53,979 | 28 May 2025 | Direct |
| William A. Hagstrom | CDNA | Common Stock | Options Exercise | 55.6% | 30,000 | 83,979 | 28 May 2025 | Direct | ||
| William A. Hagstrom | CDNA | Stock Option (right to buy) | Options Exercise | -100% | -30,000 | 0 | 28 May 2025 | Direct | ||
| Abhishek Jain | CDNA | Common Stock | Tax liability | -0.6% | -1,982 | 327,412 | 27 May 2025 | Direct |